Search
for
Sort by
Research 30 of 42
- Pharmacological Profile of 9,11-Dehydrocortexolone 17α-Butyrate (CB-03-04), a New Androgen Antagonist with Antigonadotropic Activity
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- Epitestosterone
- Pharmacodynamic Evaluation: Endocrinology
- Cyproterone Acetate: A Genotoxic Carcinogen?
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Hormonal Treatment for Skin Androgen-Related Disorders
- Is COVID-19 Gender-sensitive?
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Polycystic Ovary Syndrome: Conditions, Genetics and Current Cure
- Trilostane Treatment of Canine Alopecia X in an American Pit Bull Terrier
- Toxicity of the pharmaceuticals finasteride and melengestrol acetate to benthic invertebrates
- The role of androgen and androgen receptor in skin-related disorders
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Acneiform Dermatoses
- Androgens and Antiandrogens
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment
- Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism
- Androgen antagonists in androgen target tissues
- Idiopathic hirsutism: excessive bodily and facial hair in women
- Hirsutism
- Treatment of hyperandrogenism in women
- Herbal Hair Gel Formulation having 5α-Reductase Inhibitory Activity and its Standardization by HPTLC
- Female Antiandrogens
- Hormonal Therapy for Acne